✦ LIBER ✦

7 INVITED Developing combination therapies for hormone-refractory prostate cancer in a pre-clinical mouse model of the disease

✍ Scribed by C. Abate-Shen; C.W. Kinkade; M. Castillo-Martin; C. Cordon-Cardo

Book ID: 119599162
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 56 KB
Volume: 6
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(08)71939-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gene-directed enzyme prodrug therapy for

Gene-directed enzyme prodrug therapy for prostate cancer in a mouse model that imitates the development of human disease

✍ Rosetta Martiniello-Wilks; Allison Dane; Dale J. Voeks; Geetha Jeyakumar; Elin M 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 310 KB 👁 1 views

## Abstract ## Background Gene‐directed enzyme prodrug therapy (GDEPT) based on the __E. coli__ enzyme purine nucleoside phosphorylase (PNP) represents a new approach for treating slow growing tumours like prostate cancer (PCa). Expressed enzyme converts a systemically administered prodrug, fludar

Development of a label-free LC-MS/MS str

Development of a label-free LC-MS/MS strategy to approach the identification of candidate protein biomarkers of disease recurrence in prostate cancer patients in a clinical trial of combined hormone and radiation therapy

✍ Morrissey, Brian; O'Shea, Carmel; Armstrong, John; Rooney, Cathy; Staunton, Lisa 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 851 KB